Albuminuria Down in Adults With Newly Diagnosed T2DM
Improvements seen in glycemic, blood pressure, lipid control within the population partly explain decrease in albuminuria
TUESDAY, Jan. 12, 2021 (HealthDay News) -- From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among adults with newly diagnosed type 2 diabetes, according to a study published online Jan. 8 in Diabetes Care.
Michael Fang, Ph.D., and Elizabeth Selvin, M.P.H., Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, examined the prevalence of and trends in complications among 1,486 adults with newly diagnosed diabetes (diagnosed within the past two years) from the 1988 to 1994 and 1999 to 2018 National Health and Nutrition Examination Surveys. Trends in albuminuria, reduced estimated glomerular filtration rate (eGFR), retinopathy, and self-reported cardiovascular disease were estimated.
The researchers found a significant decrease in the prevalence of albuminuria from 1988-1994 to 2011-2018 (38.9 to 18.7 percent), but there were no significant changes in the prevalence of reduced eGFR, retinopathy, or self-reported cardiovascular disease. Within the population, there were improvements in glycemic, blood pressure, and lipid control, partly explaining the decrease in albuminuria. At the time of diabetes diagnosis, complications were more common for older, lower-income, less-educated, and obese adults.
"These results suggest that there have been improvements in diabetes screening and that we are diagnosing cases earlier in the disease process," the authors write. "Nevertheless, the overall burden of complications and uncontrolled risk factors remains high."